HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanomaterials In Cosmetics May Require Special Testing – ICCR Report

This article was originally published in The Rose Sheet

Executive Summary

A joint working group convened under the International Cooperation on Cosmetics Regulation determines that toxicological testing and risk-characterization methods for conventional ingredients are sufficient for assessing the safety of nanomaterials. However, the unique properties and behavior of nanomaterials call for modifications to existing strategies and focused evaluation of particles on the nano scale to ensure regulatory compliance and consumer welfare.

Advertisement

Related Content

FDA To Issue Guidance On Nano Cosmetics, Lead In Lipstick
ICCR Addresses Lead Limit, Endocrine Disruptors At 7th Meeting
REACH Regulators Aim For Safe Use, Not Crackdown On Nanomaterials
REACH Progress Report Cites Familiar Problems, With Some Improvement
Clinical Studies May Be Needed For Cosmetics With Nanomaterials – FDA

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS019383

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel